CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $261.76M, lower than 95% of all stocks globally
- PositionGross margin is 27.3%, lower than 95% of its Medical Devices peers (median 61%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.01%
Annual Rate
INR 0.01Paid unknown
Payout Ratio
1.1%Sustainable
Last Ex-Dividend
Sep 22, 2025
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
25.05BINR261.76M · vs all stocks (USD)
Trailing P/E
86.56xvs Medical Devices peers
Revenue (TTM)
3.09BINR32.24M · vs all stocks (USD)
Profit Margin
10.12%vs Medical Devices peers
Beta
0.0780xvs all stocks
52-Week Change
-64.33%vs all stocks
Forward Annual Dividend Yield
0.01%vs all stocks
Market Capitalization
25.05BINR261.76M · vs all stocks (USD)
Enterprise Value
25.91BINR270.69M · vs all stocks (USD)
Trailing P/E
86.56xvs Medical Devices peers
PEG Ratio
0.0866xvs Medical Devices peers
Price to Sales (TTM)
8.29xvs Medical Devices peers
Price to Book (MRQ)
6.54xvs Medical Devices peers
Enterprise to Revenue
8.39xvs Medical Devices peers
Enterprise to EBITDA
63.55xvs Medical Devices peers
Gross Margin
27.32%vs Medical Devices peers
Profit Margin
10.12%vs Medical Devices peers
Operating Margin
0.08%vs Medical Devices peers
Return on Assets (TTM)
4.44%vs Medical Devices peers
Return on Equity (TTM)
8.63%vs Medical Devices peers
Revenue (TTM)
3.09BINR32.24M · vs all stocks (USD)
Revenue per Share (TTM)
4.74INRUpdated Aug 21, 2026Quarterly Revenue Growth
98.70%vs Medical Devices peers
Gross Profit (TTM)
1.13BINR11.81M · vs all stocks (USD)
EBITDA (TTM)
391.42MINR4.09M · vs all stocks (USD)
Net Income (TTM)
312.41MINR3.26M · vs all stocks (USD)
Operating Cash Flow (TTM)
-1.01BINR-10.58M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
310.19MINR3.24M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0100INRUpdated Aug 21, 2026Forward Annual Dividend Yield
0.01%vs all stocks
Trailing Annual Dividend Rate
0.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
1.11%vs Medical Devices peers
Minority Interest (Equity)
7.57MINRFY2026 · Mar 31, 2026Revenue
3.09BINRFY2026 · Mar 31, 2026Cost of Goods Sold
1.96BINRFY2026 · Mar 31, 2026Gross Profit
1.13BINRFY2026 · Mar 31, 2026Operating Income
401.04MINR4.19M · vs all stocks (USD)
Pre-tax Income
463.62MINRFY2026 · Mar 31, 2026Income Tax Expense
153.43MINRFY2026 · Mar 31, 2026Net Income
310.19MINRFY2026 · Mar 31, 2026EBIT
521.96MINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
551.75MINRFY2026 · Mar 31, 2026Other Operating Expenses
548.08MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
58.34MINRFY2026 · Mar 31, 2026Net Income from Continuing Operations
453.94MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
-2.36BINRFY2026 · Mar 31, 2026Free Cash Flow
-2.37BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
118.89MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
453.94MINRFY2026 · Mar 31, 2026Other Non-cash Items
50.01MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-2.16BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-702.45MINRFY2026 · Mar 31, 2026Capital Expenditures
-13.11MINRFY2026 · Mar 31, 2026Purchase of Investments
-1.14BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-1.16BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-16.00KINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
76.40MINRFY2026 · Mar 31, 2026Common Dividends Paid
-2.74MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
205.09MINRFY2026 · Mar 31, 2026Shares Outstanding
654.52MSharesUpdated Aug 21, 2026Float Shares
166.23MSharesUpdated Aug 21, 2026% Held by Insiders
73.90%vs all stocks
% Held by Institutions
2.46%vs all stocks
Total Cash (MRQ)
250.46MINR2.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3880INRUpdated Aug 21, 2026Total Debt (MRQ)
1.07BINR11.19M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2770xvs Medical Devices peers
Current Ratio (MRQ)
1.60xvs Medical Devices peers
Book Value per Share (MRQ)
5.96INRUpdated Aug 21, 2026Total Assets
6.71BINR70.11M · vs all stocks (USD)
Total Current Assets
4.18BINRFY2026 · Mar 31, 2026Total Liabilities
2.86BINRFY2026 · Mar 31, 2026Total Non-current Assets
2.53BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
278.43MINRFY2026 · Mar 31, 2026Total Current Liabilities
2.58BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
118.89MINRFY2026 · Mar 31, 2026Other Short-term Investments
196.60MINRFY2026 · Mar 31, 2026Accounts Receivable
2.89BINRFY2026 · Mar 31, 2026Inventory
126.63MINRFY2026 · Mar 31, 2026Accounts Payable
1.03BINRFY2026 · Mar 31, 2026Short-term Debt
802.20MINRFY2026 · Mar 31, 2026Other Current Liabilities
134.21MINRFY2026 · Mar 31, 2026Long-term Debt
268.55MINRFY2026 · Mar 31, 2026Other Non-current Liabilities
2.00KINRFY2026 · Mar 31, 2026Common Stock (Book)
654.51MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
3.85BINR40.24M · vs all stocks (USD)
52-Week Low
31.05INRUpdated Aug 21, 202652-Week High
124.70INRUpdated Aug 21, 202652-Week Change
-64.33%vs all stocks
Beta
0.0780xvs all stocks
50-Day MA
37.81INRUpdated Aug 21, 2026200-Day MA
39.30INRUpdated Aug 21, 2026Avg 10-Day Volume
1.34MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.23MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.4500INRUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 27.3%, lower than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.27Industry median: 0.61Industry P5: 0.28Peers compared: 102
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 3,264,414.053Operating Cash Flow (USD, TTM): -10,581,336.585
Financial Health
Altman Z-Score 6.3: safe zoneNotable
Altman Z-Score: 6.30
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $261.76M, lower than 95% of all stocks globallySignificant
Market cap (USD): 261,757,293.219Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Niagen Bioscience Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Hunan Nucien Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
TriSalus Life Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ginwa Enterprise Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Senseonics Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
PharmaEngine, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Entrada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tiansheng Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Surrozen, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
United Orthopedic Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Moura Dubeux Engenharia S.A.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthReceivables Heavy and Growing
Krishana Phoschem Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthReceivables Heavy and Growing
Coforge Limited
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthReceivables Heavy and Growing